Reports
Reports
Recent advancements in stem cell research have raised the awareness about cellular development and differentiation. The present scenario is such that advancements with stem-cell-derived organoids are aiming to be as close to the structures and functions of real organs as possible, and provide the most unique models for studying human biology and disease.
In addition, growing demand for personalized medicine has led to greater emphasis on patient-specific modeling of organoids, where drug action against a particular genotype can be screened, and organoids do have immense potential in tissue engineering with the possibility of designing individualized tissues and organs to be transplanted to mitigate donor organ scarcity.
Technological innovations such as microfluidics and 3D bioprinting are facilitating the enhancement of the organoid function toward increasingly sophisticated experimentation and analysis. Organoid market, therefore, is not only growing on the basis of application but also changing as a result of persistent pressure for increasingly precise and reliable research tools.
One of the most significant trends is the growing use of organoids in drug discovery and development. Organoid models are increasingly utilized by pharmaceuticals for preclinical research due to the fact that the systems more accurately represent human tissue than two-dimensional cell cultures. The change allows for more accurate predictions to be made about the efficacy and toxicity of drugs while providing much reduced probabilities of failure in final-stage clinical trials.
The market is also benefiting from increased funding and investment from both - public and private sectors. With growing awareness of the prospect for applications of organoids, growing venture capital and grants are being poured into research and development activities in the area. Also, collaborative research between academic institutions, biotech companies, and pharmaceutical companies is creating a fertile ground for innovation.
Organoids are miniaturized, three-dimensional structures derived from stem cells that replicate the functional and architectural characteristics of real organs. Organoids are self-organizing structures that have the same complexity as human tissue and organs, and can serve as a platform for making paradigm-changing advancements in biomedical science. Organoids are useful mainly as they expand from two-dimensional cell culture, which is a more representative physiology, allowing scientist to study interaction of cells and development of tissues and disease in a more realistic manner.
The applications of organoids are vast and varied. Organoids provide a platform for the testing of new drug’s effect and toxicity in drug development, thereby facilitating more representative models of the human response. Organoids generated from tumor tissue are employed to explore the dynamics of tumors, identify possible therapeutic targets, and also determine personalized treatment in the field of cancer research.
Besides, organoids play a vital role in regenerative medicine as they can provide information on tissue development and potential organ replacement or repair methods.
There are several types of organoids categorized on the basis of the organ systems they represent. Intestinal organoids, for example, are used for investigation of gastrointestinal disease and nutrient uptake, while liver organoids enable hepatic disease research and drug metabolism. Brain organoids help with investigation of neurological disease and brain development. Kidney, lung, and pancreatic organoids are the ones whose purposes of investigation as well as expanding the knowledge of human biology are distinct. With continued growth in research, organoids will play increasingly important roles in advancing medicine and improving patient outcomes.
| Attribute | Detail |
|---|---|
| Organoids Market Drivers |
|
Advances in stem cell research are a key driver to the organoids market, dramatically increasing the functionality and utility of these novel biological models. Stem cells can differentiate into many different cell types, a key property to creating organoids with structure and function very close to that of real human organs.
Improvements in the methodology of stem cell isolation, culture, and differentiation have enabled the derivation of organoids from adult and pluripotent stem cells more reproducibly and efficiently. The implementation of these improvements has made it possible to derive organoids that are physiologically similar to some tissues, yielding precious information about human disease and biology.
Significant progress has been made in stem cell research over the last 10 years, most notably with the emergence of induced pluripotent stem cells (iPSCs) that are adult cells re-programmed to a state more like embryonic stem cells. This technology not only avoids the ethical problems related to embryonic stem cells; but could also be used to create patient-specific organoids. By separating organoids from a patient's iPSCs, scientists are able to investigate disease mechanisms in conditions closely replicating the patient's own individual genetic environment. This is a key consideration for personalized medicine as it opens up the possibility of personalized therapeutic strategies based on individual drug and treatment response.
In addition, new gene editing tools such as CRISPR-Cas9 have allowed for precise modification of stem cells to create defined gene-altered organoids. This is of huge significance in disease modeling of genetic disease, tumorigenesis research, and determining the effects of therapeutic candidates. By creating organoids with deletion or mutation specific to disease, scientists can gain more insights into the mechanistic underpinnings of many diseases and reveal new therapeutic approaches.
In addition, advancements in more sophisticated culture methods including 3D bioprinting and organ-on-a-chip systems have enhanced organoid development and function. Methods enable various varieties of cell types and extracellular matrix components to be combined in trying to create more sophisticated, more biologically relevant organoid morphologies. All these advancements enhance not only the biological significance of organoids but also their use in drug discovery and development, toxicity screening, and regenerative medicine.
Growing need for personalized medicine is the key growth driver to the organoids market, a new healthcare industry trend toward individualized treatment protocols from the patient's tailored profile. Personalized medicine is centered on maximizing the therapeutic effect by considering the patient's tailored genetic, environmental, and lifestyle factors that influence patient responsiveness to therapy. Organoids spearhead this process as state-of-the-art devices that facilitate the development of tailored treatment protocols.
Organoids derived from the cells of a patient provide a unique platform to investigate disease pathophysiology and drug response in a configuration closely approaching true human physiology. By producing organoids of a patient's tumor cells, researchers can trace the tumor's response to various chemotherapeutic agents or targeted therapies in real time. This may facilitate the identification of the best therapy for the patient and improve the clinical outcome with fewer side-effects.
Further, organoids are not just used in precision medicine for cancer. Organoids are also utilized in cardiology, infectious disease, and neurology, where patient-derived organoids can be utilized to explore how a particular genetic mutation or disease state affects drug response. This ability does not only allow to learn more about different conditions but also assist in developing therapies specifically tailored to meet the unique needs of an individual patient.
The clinical application of organoid technology is also enabled by genomics and bioinformatics advances that enable the handling of the patient's data to be utilized in the decision for treatment. With healthcare systems also moving toward personalized medicine models, there would be growing demand for organoids as tools for research and therapy.
Developmental biology segment captures the majority share in the global organoids market. This is due to the fact that organoids have provided unprecedented information about organ developmental processes, and it is now possible to experiment on cell differentiation and tissue formation in a controlled setting. This is a crucial ability in interpreting congenital malformations and developmental disorders, which are continuously being found to be more complex in nature. Further, the ability to model organogenesis with organoids provides an avenue for the study of intricate signaling pathways and cellular interactions that propel development.
In addition, the increasing focus on regenerative medicine provides impetus to developmental biology. Organoids obtained from stem cells can be used as models for tissue regeneration and repair, thereby making it easier to develop therapeutic approaches toward the restoration of injured organs.
| Attribute | Detail |
|---|---|
| Leading Region | North America |
As per the latest organoids market analysis, North America dominated in the market in 2024 due to strong research infrastructure owned by the region, high level of funding, and robust focus on innovation in biotechnology. The region is home to top research institutes and universities of the U.S. and Canada, which provide a rich ecosystem for organoids-oriented R&D.
In addition, North America is backed up by huge government and private investments in biotechnology and life sciences research. The national governmental organizations, such as the National Institutes of Health (NIH), provide grants and funding programs directly to aid stem cell studies and regenerative medicine, which are crucial to organoid development.
High acceptability and awareness of sophisticated medical technologies such as organoids also propel North America. Organoid models are increasingly being applied by healthcare practitioners and pharmaceutical firms within the region for drug development as well as targeted medicine, leveraging their potential to enhance therapeutic efficacy.
Several companies engaged in the organoids market are planning to create customized organoid models of different organs to enable drug discovery and disease modeling. Companies are also pursuing grants and investments to fund novel organoid studies, and incorporating cutting-edge technologies such as 3D bioprinting and microfluidics in a bid to enhance organoid complexity and functionality.
Danaher Corporation, Merck KGaA, 3Dnamics Inc., ATCC, STEMCELL Technologies, CelVivo ApS, Emulate, Inc., Newcells Biotech, ACROBiosystems, Corning Incorporated, Pandorum Technologies Pvt. Ltd., MIMETAS B.V., Organovo Holdings Inc., Crown Bioscience and OrganoTherapeutics SARL are some of the leading players operating in the global organoids market.
Each of these players has been profiled in the organoids market research report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.
| Attribute | Detail |
|---|---|
| Size in 2024 | US$ 1.1 Bn |
| Forecast Value in 2035 | US$ 4.2 Bn |
| CAGR | 13.4% |
| Forecast Period | 2025-2035 |
| Historical Data Available for | 2020-2023 |
| Quantitative Units | US$ Bn |
| Biotechnology Market Analysis | It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available upon request |
| Pricing | Available upon request |
The global Organoids market was valued at US$ 1.1 Bn in 2024.
The global Organoids industry is projected to reach more than US$ 4.2 Bn by the end of 2035.
Ongoing advancements in stem cell research, rising demand for personalized medicine, and growing focus on regenerative medicine are the factors driving the expansion of Organoids market.
The CAGR is anticipated to be 13.4% from 2025 to 2035.
Danaher Corporation, Merck KGaA, 3Dnamics Inc., ATCC, STEMCELL Technologies, CelVivo ApS, Emulate, Inc., Newcells Biotech, ACROBiosystems, Corning Incorporated, Pandorum Technologies Pvt. Ltd., MIMETAS B.V., Organovo Holdings Inc., Crown Bioscience and OrganoTherapeutics SARL.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Organoids Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Organoids Market Analysis and Forecasts, 2020 to 2035
4.4.1. Market Revenue Projections (US$ Bn)
5. Key Insights
5.1. Healthcare Expenditure across Key Regions / Countries
5.2. Recent Advancements in Organoid Technology
5.3. Pricing Trends for Organoids
5.4. Regulatory Scenario across Key Regions / Countries
5.5. PORTER’s Five Forces Analysis
5.6. PESTEL Analysis
5.7. Value Chain Analysis
5.8. Key Purchase Metrics for End-users
5.9. Go-to-Market Strategy for New Market Entrants
5.10. Key Industry Events (Partnerships, Collaborations, Product approvals, mergers & acquisitions)
5.11. Benchmarking of Key Products Offered by the Leading Competitors
6. Global Organoids Market Analysis and Forecasts, By Type of Organoid
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast By Type of Organoid, 2020 to 2035
6.3.1. Stomach Organoids
6.3.2. Intestinal Organoids
6.3.3. Liver Organoids
6.3.4. Lung Organoids
6.3.5. Brain Organoids
6.3.6. Kidney Organoids
6.3.7. Colorectal Organoids
6.3.8. Breast Organoids
6.3.9. Prostate Organoids
6.3.10. Skin Organoids
6.3.11. Retina Organoids
6.3.12. Others
6.4. Market Attractiveness By Type of Organoid
7. Global Organoids Market Analysis and Forecasts, By Source
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast By Source, 2020 to 2035
7.3.1. Pluripotent Stem Cells (PSCs)
7.3.1.1. Embryonic Stem Cells (ESCs)
7.3.1.2. Induced Pluripotent Stem Cells (iPSCs)
7.3.2. Adult Stem Cells (ASCs)
7.3.3. Patient-derived Organoids
7.4. Market Attractiveness By Source
8. Global Organoids Market Analysis and Forecasts, By Application
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast By Application, 2020 to 2035
8.3.1. Developmental Biology
8.3.2. Regenerative Medicine
8.3.3. Disease Modelling
8.3.4. Drug Toxicity and Efficacy Testing
8.3.5. Biomarker Discovery
8.3.6. Others
8.4. Market Attractiveness By Application
9. Global Organoids Market Analysis and Forecasts, By Usability
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Market Value Forecast By Usability, 2020 to 2035
9.3.1. Ready-to-Use Organoids
9.3.2. Customizable Organoids
9.4. Market Attractiveness By Usability
10. Global Organoids Market Analysis and Forecasts, By Storage Conditions
10.1. Introduction & Definition
10.2. Key Findings / Developments
10.3. Market Value Forecast By Storage Conditions, 2020 to 2035
10.3.1. Shelf-stable Organoids
10.3.2. Cryopreserved Organoids
10.4. Market Attractiveness By Storage Conditions
11. Global Organoids Market Analysis and Forecasts, By End-user
11.1. Introduction & Definition
11.2. Key Findings / Developments
11.3. Market Value Forecast By End-user, 2020 to 2035
11.3.1. Pharmaceutical and Biotechnology Companies
11.3.2. Contract Research Organizations (CROs)
11.3.3. Academic and Research Institutions
11.4. Market Attractiveness By End-user
12. Global Organoids Market Analysis and Forecasts, By Region
12.1. Key Findings
12.2. Market Value Forecast By Region
12.2.1. North America
12.2.2. Europe
12.2.3. Asia Pacific
12.2.4. Latin America
12.2.5. Middle East & Africa
12.3. Market Attractiveness By Region
13. North America Organoids Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast By Type of Organoid, 2020 to 2035
13.2.1. Stomach Organoids
13.2.2. Intestinal Organoids
13.2.3. Liver Organoids
13.2.4. Lung Organoids
13.2.5. Brain Organoids
13.2.6. Kidney Organoids
13.2.7. Colorectal Organoids
13.2.8. Breast Organoids
13.2.9. Prostate Organoids
13.2.10. Skin Organoids
13.2.11. Retina Organoids
13.2.12. Others
13.3. Market Value Forecast By Source, 2020 to 2035
13.3.1. Pluripotent Stem Cells (PSCs)
13.3.1.1. Embryonic Stem Cells (ESCs)
13.3.1.2. Induced Pluripotent Stem Cells (iPSCs)
13.3.2. Adult Stem Cells (ASCs)
13.3.3. Patient-derived Organoids
13.4. Market Value Forecast By Application, 2020 to 2035
13.4.1. Developmental Biology
13.4.2. Regenerative Medicine
13.4.3. Disease Modelling
13.4.4. Drug Toxicity and Efficacy Testing
13.4.5. Biomarker Discovery
13.4.6. Others
13.5. Market Value Forecast By Usability, 2020 to 2035
13.5.1. Ready-to-Use Organoids
13.5.2. Customizable Organoids
13.6. Market Value Forecast By Storage Conditions, 2020 to 2035
13.6.1. Shelf-stable Organoids
13.6.2. Cryopreserved Organoids
13.7. Market Value Forecast By End-user, 2020 to 2035
13.7.1. Pharmaceutical and Biotechnology Companies
13.7.2. Contract Research Organizations (CROs)
13.7.3. Academic and Research Institutions
13.8. Market Value Forecast By Country , 2020 to 2035
13.8.1. U.S.
13.8.2. Canada
13.9. Market Attractiveness Analysis
13.9.1. By Type of Organoid
13.9.2. By Source
13.9.3. By Application
13.9.4. By Usability
13.9.5. By Storage Conditions
13.9.6. By End-user
13.9.7. By Country
14. Europe Organoids Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast By Type of Organoid, 2020 to 2035
14.2.1. Stomach Organoids
14.2.2. Intestinal Organoids
14.2.3. Liver Organoids
14.2.4. Lung Organoids
14.2.5. Brain Organoids
14.2.6. Kidney Organoids
14.2.7. Colorectal Organoids
14.2.8. Breast Organoids
14.2.9. Prostate Organoids
14.2.10. Skin Organoids
14.2.11. Retina Organoids
14.2.12. Others
14.3. Market Value Forecast By Source, 2020 to 2035
14.3.1. Pluripotent Stem Cells (PSCs)
14.3.1.1. Embryonic Stem Cells (ESCs)
14.3.1.2. Induced Pluripotent Stem Cells (iPSCs)
14.3.2. Adult Stem Cells (ASCs)
14.3.3. Patient-derived Organoids
14.4. Market Value Forecast By Application, 2020 to 2035
14.4.1. Developmental Biology
14.4.2. Regenerative Medicine
14.4.3. Disease Modelling
14.4.4. Drug Toxicity and Efficacy Testing
14.4.5. Biomarker Discovery
14.4.6. Others
14.5. Market Value Forecast By Usability, 2020 to 2035
14.5.1. Ready-to-Use Organoids
14.5.2. Customizable Organoids
14.6. Market Value Forecast By Storage Conditions, 2020 to 2035
14.6.1. Shelf-stable Organoids
14.6.2. Cryopreserved Organoids
14.7. Market Value Forecast By End-user, 2020 to 2035
14.7.1. Pharmaceutical and Biotechnology Companies
14.7.2. Contract Research Organizations (CROs)
14.7.3. Academic and Research Institutions
14.8. Market Value Forecast By Country / Sub-region , 2020 to 2035
14.8.1. Germany
14.8.2. UK
14.8.3. France
14.8.4. Italy
14.8.5. Spain
14.8.6. Switzerland
14.8.7. The Netherlands
14.8.8. Rest of Europe
14.9. Market Attractiveness Analysis
14.9.1. By Type of Organoid
14.9.2. By Source
14.9.3. By Application
14.9.4. By Usability
14.9.5. By Storage Conditions
14.9.6. By End-user
14.9.7. By Country / Sub-region
15. Asia Pacific Organoids Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast By Type of Organoid, 2020 to 2035
15.2.1. Stomach Organoids
15.2.2. Intestinal Organoids
15.2.3. Liver Organoids
15.2.4. Lung Organoids
15.2.5. Brain Organoids
15.2.6. Kidney Organoids
15.2.7. Colorectal Organoids
15.2.8. Breast Organoids
15.2.9. Prostate Organoids
15.2.10. Skin Organoids
15.2.11. Retina Organoids
15.2.12. Others
15.3. Market Value Forecast By Source, 2020 to 2035
15.3.1. Pluripotent Stem Cells (PSCs)
15.3.1.1. Embryonic Stem Cells (ESCs)
15.3.1.2. Induced Pluripotent Stem Cells (iPSCs)
15.3.2. Adult Stem Cells (ASCs)
15.3.3. Patient-derived Organoids
15.4. Market Value Forecast By Application, 2020 to 2035
15.4.1. Developmental Biology
15.4.2. Regenerative Medicine
15.4.3. Disease Modelling
15.4.4. Drug Toxicity and Efficacy Testing
15.4.5. Biomarker Discovery
15.4.6. Others
15.5. Market Value Forecast By Usability, 2020 to 2035
15.5.1. Ready-to-Use Organoids
15.5.2. Customizable Organoids
15.6. Market Value Forecast By Storage Conditions, 2020 to 2035
15.6.1. Shelf-stable Organoids
15.6.2. Cryopreserved Organoids
15.7. Market Value Forecast By End-user, 2020 to 2035
15.7.1. Pharmaceutical and Biotechnology Companies
15.7.2. Contract Research Organizations (CROs)
15.7.3. Academic and Research Institutions
15.8. Market Value Forecast By Country / Sub-region , 2020 to 2035
15.8.1. China
15.8.2. India
15.8.3. Japan
15.8.4. South Korea
15.8.5. Australia & New Zealand
15.8.6. Rest of Asia Pacific
15.9. Market Attractiveness Analysis
15.9.1. By Type of Organoid
15.9.2. By Source
15.9.3. By Application
15.9.4. By Usability
15.9.5. By Storage Conditions
15.9.6. By End-user
15.9.7. By Country / Sub-region
16. Latin America Organoids Market Analysis and Forecast
16.1. Introduction
16.1.1. Key Findings
16.2. Market Value Forecast By Type of Organoid, 2020 to 2035
16.2.1. Stomach Organoids
16.2.2. Intestinal Organoids
16.2.3. Liver Organoids
16.2.4. Lung Organoids
16.2.5. Brain Organoids
16.2.6. Kidney Organoids
16.2.7. Colorectal Organoids
16.2.8. Breast Organoids
16.2.9. Prostate Organoids
16.2.10. Skin Organoids
16.2.11. Retina Organoids
16.2.12. Others
16.3. Market Value Forecast By Source, 2020 to 2035
16.3.1. Pluripotent Stem Cells (PSCs)
16.3.1.1. Embryonic Stem Cells (ESCs)
16.3.1.2. Induced Pluripotent Stem Cells (iPSCs)
16.3.2. Adult Stem Cells (ASCs)
16.3.3. Patient-derived Organoids
16.4. Market Value Forecast By Application, 2020 to 2035
16.4.1. Developmental Biology
16.4.2. Regenerative Medicine
16.4.3. Disease Modelling
16.4.4. Drug Toxicity and Efficacy Testing
16.4.5. Biomarker Discovery
16.4.6. Others
16.5. Market Value Forecast By Usability, 2020 to 2035
16.5.1. Ready-to-Use Organoids
16.5.2. Customizable Organoids
16.6. Market Value Forecast By Storage Conditions, 2020 to 2035
16.6.1. Shelf-stable Organoids
16.6.2. Cryopreserved Organoids
16.7. Market Value Forecast By End-user, 2020 to 2035
16.7.1. Pharmaceutical and Biotechnology Companies
16.7.2. Contract Research Organizations (CROs)
16.7.3. Academic and Research Institutions
16.8. Market Value Forecast By Country / Sub-region , 2020 to 2035
16.8.1. Brazil
16.8.2. Mexico
16.8.3. Argentina
16.8.4. Rest of Latin America
16.9. Market Attractiveness Analysis
16.9.1. By Type of Organoid
16.9.2. By Source
16.9.3. By Application
16.9.4. By Usability
16.9.5. By Storage Conditions
16.9.6. By End-user
16.9.7. By Country / Sub-region
17. Middle East & Africa Organoids Market Analysis and Forecast
17.1. Introduction
17.1.1. Key Findings
17.2. Market Value Forecast By Type of Organoid, 2020 to 2035
17.2.1. Stomach Organoids
17.2.2. Intestinal Organoids
17.2.3. Liver Organoids
17.2.4. Lung Organoids
17.2.5. Brain Organoids
17.2.6. Kidney Organoids
17.2.7. Colorectal Organoids
17.2.8. Breast Organoids
17.2.9. Prostate Organoids
17.2.10. Skin Organoids
17.2.11. Retina Organoids
17.2.12. Others
17.3. Market Value Forecast By Source, 2020 to 2035
17.3.1. Pluripotent Stem Cells (PSCs)
17.3.1.1. Embryonic Stem Cells (ESCs)
17.3.1.2. Induced Pluripotent Stem Cells (iPSCs)
17.3.2. Adult Stem Cells (ASCs)
17.3.3. Patient-derived Organoids
17.4. Market Value Forecast By Application, 2020 to 2035
17.4.1. Developmental Biology
17.4.2. Regenerative Medicine
17.4.3. Disease Modelling
17.4.4. Drug Toxicity and Efficacy Testing
17.4.5. Biomarker Discovery
17.4.6. Others
17.5. Market Value Forecast By Usability, 2020 to 2035
17.5.1. Ready-to-Use Organoids
17.5.2. Customizable Organoids
17.6. Market Value Forecast By Storage Conditions, 2020 to 2035
17.6.1. Shelf-stable Organoids
17.6.2. Cryopreserved Organoids
17.7. Market Value Forecast By End-user, 2020 to 2035
17.7.1. Pharmaceutical and Biotechnology Companies
17.7.2. Contract Research Organizations (CROs)
17.7.3. Academic and Research Institutions
17.8. Market Value Forecast By Country / Sub-region , 2020 to 2035
17.8.1. GCC Countries
17.8.2. South Africa
17.8.3. Rest of Middle East & Africa
17.9. Market Attractiveness Analysis
17.9.1. By Type of Organoid
17.9.2. By Source
17.9.3. By Application
17.9.4. By Usability
17.9.5. By Storage Conditions
17.9.6. By End-user
17.9.7. By Country / Sub-region
18. Competition Landscape
18.1. Market Player – Competition Matrix (By Tier and Size of companies)
18.2. Market Share Analysis By Company (2024)
18.3. Company Profiles
18.3.1. Danaher Corporation
18.3.1.1. Company Overview
18.3.1.2. Financial Overview
18.3.1.3. Product Portfolio
18.3.1.4. Business Strategies
18.3.1.5. Recent Developments
18.3.2. Merck KGaA
18.3.2.1. Company Overview
18.3.2.2. Financial Overview
18.3.2.3. Product Portfolio
18.3.2.4. Business Strategies
18.3.2.5. Recent Developments
18.3.3. 3Dnamics Inc.
18.3.3.1. Company Overview
18.3.3.2. Financial Overview
18.3.3.3. Product Portfolio
18.3.3.4. Business Strategies
18.3.3.5. Recent Developments
18.3.4. ATCC
18.3.4.1. Company Overview
18.3.4.2. Financial Overview
18.3.4.3. Product Portfolio
18.3.4.4. Business Strategies
18.3.4.5. Recent Developments
18.3.5. STEMCELL Technologies
18.3.5.1. Company Overview
18.3.5.2. Financial Overview
18.3.5.3. Product Portfolio
18.3.5.4. Business Strategies
18.3.5.5. Recent Developments
18.3.6. CelVivo ApS
18.3.6.1. Company Overview
18.3.6.2. Financial Overview
18.3.6.3. Product Portfolio
18.3.6.4. Business Strategies
18.3.6.5. Recent Developments
18.3.7. Emulate, Inc.
18.3.7.1. Company Overview
18.3.7.2. Financial Overview
18.3.7.3. Product Portfolio
18.3.7.4. Business Strategies
18.3.7.5. Recent Developments
18.3.8. Newcells Biotech
18.3.8.1. Company Overview
18.3.8.2. Financial Overview
18.3.8.3. Product Portfolio
18.3.8.4. Business Strategies
18.3.8.5. Recent Developments
18.3.9. ACROBiosystems
18.3.9.1. Company Overview
18.3.9.2. Financial Overview
18.3.9.3. Product Portfolio
18.3.9.4. Business Strategies
18.3.9.5. Recent Developments
18.3.10. Corning Incorporated
18.3.10.1. Company Overview
18.3.10.2. Financial Overview
18.3.10.3. Product Portfolio
18.3.10.4. Business Strategies
18.3.10.5. Recent Developments
18.3.11. Pandorum Technologies Pvt. Ltd.
18.3.11.1. Company Overview
18.3.11.2. Financial Overview
18.3.11.3. Product Portfolio
18.3.11.4. Business Strategies
18.3.11.5. Recent Developments
18.3.12. MIMETAS B.V.
18.3.12.1. Company Overview
18.3.12.2. Financial Overview
18.3.12.3. Product Portfolio
18.3.12.4. Business Strategies
18.3.12.5. Recent Developments
18.3.13. Organovo Holdings Inc.
18.3.13.1. Company Overview
18.3.13.2. Financial Overview
18.3.13.3. Product Portfolio
18.3.13.4. Business Strategies
18.3.13.5. Recent Developments
18.3.14. Crown Bioscience
18.3.14.1. Company Overview
18.3.14.2. Financial Overview
18.3.14.3. Product Portfolio
18.3.14.4. Business Strategies
18.3.14.5. Recent Developments
18.3.15. OrganoTherapeutics SARL
18.3.15.1. Company Overview
18.3.15.2. Financial Overview
18.3.15.3. Product Portfolio
18.3.15.4. Business Strategies
18.3.15.5. Recent Developments
List of Tables
Table 01: Global Organoids Market Value (US$ Bn) Forecast, By Type of Organoid, 2020 to 2035
Table 02: Global Organoids Market Value (US$ Bn) Forecast, By Source, 2020 to 2035
Table 03: Global Organoids Market Value (US$ Bn) Forecast, By Pluripotent Stem Cells (PSCs), 2020 to 2035
Table 04: Global Organoids Market Value (US$ Bn) Forecast, By Application, 2020 to 2035
Table 05: Global Organoids Market Value (US$ Bn) Forecast, By Usability, 2020 to 2035
Table 06: Global Organoids Market Value (US$ Bn) Forecast, By Storage Conditions, 2020 to 2035
Table 07: Global Organoids Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035
Table 08: Global Organoids Market Value (US$ Bn) Forecast, By Region, 2020 to 2035
Table 09: North America Organoids Market Value (US$ Bn) Forecast, by Country, 2020 to 2035
Table 10: North America Organoids Market Value (US$ Bn) Forecast, By Type of Organoid, 2020 to 2035
Table 11: North America Organoids Market Value (US$ Bn) Forecast, By Source, 2020 to 2035
Table 12: North America Organoids Market Value (US$ Bn) Forecast, By Pluripotent Stem Cells (PSCs), 2020 to 2035
Table 13: North America Organoids Market Value (US$ Bn) Forecast, By Application, 2020 to 2035
Table 14: North America Organoids Market Value (US$ Bn) Forecast, By Usability, 2020 to 2035
Table 15: North America Organoids Market Value (US$ Bn) Forecast, By Storage Conditions, 2020 to 2035
Table 16: North America Organoids Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035
Table 17: Europe Organoids Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020 to 2035
Table 18: Europe Organoids Market Value (US$ Bn) Forecast, By Type of Organoid, 2020 to 2035
Table 19: Europe Organoids Market Value (US$ Bn) Forecast, By Source, 2020 to 2035
Table 20: Europe Organoids Market Value (US$ Bn) Forecast, By Pluripotent Stem Cells (PSCs), 2020 to 2035
Table 21: Europe Organoids Market Value (US$ Bn) Forecast, By Application, 2020 to 2035
Table 22: Europe Organoids Market Value (US$ Bn) Forecast, By Usability, 2020 to 2035
Table 23: Europe Organoids Market Value (US$ Bn) Forecast, By Storage Conditions, 2020 to 2035
Table 24: Europe Organoids Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035
Table 25: Asia Pacific Organoids Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020 to 2035
Table 26: Asia Pacific Organoids Market Value (US$ Bn) Forecast, By Type of Organoid, 2020 to 2035
Table 27: Asia Pacific Organoids Market Value (US$ Bn) Forecast, By Source, 2020 to 2035
Table 28: Asia Pacific Organoids Market Value (US$ Bn) Forecast, By Pluripotent Stem Cells (PSCs), 2020 to 2035
Table 29: Asia Pacific Organoids Market Value (US$ Bn) Forecast, By Application, 2020 to 2035
Table 30: Asia Pacific Organoids Market Value (US$ Bn) Forecast, By Usability, 2020 to 2035
Table 31: Asia Pacific Organoids Market Value (US$ Bn) Forecast, By Storage Conditions, 2020 to 2035
Table 32: Asia Pacific Organoids Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035
Table 33: Latin America Organoids Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020 to 2035
Table 34: Asia Pacific Organoids Market Value (US$ Bn) Forecast, By Type of Organoid, 2020 to 2035
Table 35: Latin America Organoids Market Value (US$ Bn) Forecast, By Source, 2020 to 2035
Table 36: Latin America Organoids Market Value (US$ Bn) Forecast, By Pluripotent Stem Cells (PSCs), 2020 to 2035
Table 37: Latin America Organoids Market Value (US$ Bn) Forecast, By Application, 2020 to 2035
Table 38: Latin America Organoids Market Value (US$ Bn) Forecast, By Usability, 2020 to 2035
Table 39: Latin America Organoids Market Value (US$ Bn) Forecast, By Storage Conditions, 2020 to 2035
Table 40: Latin America Organoids Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035
Table 41: Middle East & Africa Organoids Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020 to 2035
Table 42: Middle East & Africa Organoids Market Value (US$ Bn) Forecast, By Type of Organoid, 2020 to 2035
Table 43: Middle East & Africa Organoids Market Value (US$ Bn) Forecast, By Source, 2020 to 2035
Table 44: Middle East & Africa Organoids Market Value (US$ Bn) Forecast, By Pluripotent Stem Cells (PSCs), 2020 to 2035
Table 45: Middle East & Africa Organoids Market Value (US$ Bn) Forecast, By Application, 2020 to 2035
Table 46: Middle East & Africa Organoids Market Value (US$ Bn) Forecast, By Usability, 2020 to 2035
Table 47: Middle East & Africa Organoids Market Value (US$ Bn) Forecast, By Storage Conditions, 2020 to 2035
Table 48: Middle East & Africa Organoids Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035
List of Figures
Figure 01: Global Organoids Market Value Share Analysis, By Type of Organoid, 2024 and 2035
Figure 02: Global Organoids Market Attractiveness Analysis, By Type of Organoid, 2025 to 2035
Figure 03: Global Organoids Market Revenue (US$ Bn), by Stomach Organoids, 2020 to 2035
Figure 04: Global Organoids Market Revenue (US$ Bn), by Intestinal Organoids, 2020 to 2035
Figure 05: Global Organoids Market Revenue (US$ Bn), by Liver Organoids, 2020 to 2035
Figure 06: Global Organoids Market Revenue (US$ Bn), by Lung Organoids, 2020 to 2035
Figure 07: Global Organoids Market Revenue (US$ Bn), by Brain Organoids, 2020 to 2035
Figure 08: Global Organoids Market Revenue (US$ Bn), by Kidney Organoids, 2020 to 2035
Figure 09: Global Organoids Market Revenue (US$ Bn), by Colorectal Organoids, 2020 to 2035
Figure 10: Global Organoids Market Revenue (US$ Bn), by Breast Organoids, 2020 to 2035
Figure 11: Global Organoids Market Revenue (US$ Bn), by Prostate Organoids, 2020 to 2035
Figure 12: Global Organoids Market Revenue (US$ Bn), by Skin Organoids, 2020 to 2035
Figure 13: Global Organoids Market Revenue (US$ Bn), by Retina Organoids, 2020 to 2035
Figure 14: Global Organoids Market Revenue (US$ Bn), by Others, 2020 to 2035
Figure 15: Global Organoids Market Value Share Analysis, By Source, 2024 and 2035
Figure 16: Global Organoids Market Attractiveness Analysis, By Source, 2025 to 2035
Figure 17: Global Organoids Market Revenue (US$ Bn), by Pluripotent Stem Cells (PSCs), 2020 to 2035
Figure 18: Global Organoids Market Revenue (US$ Bn), by Adult Stem Cells (ASCs), 2020 to 2035
Figure 19: Global Organoids Market Revenue (US$ Bn), by Patient-derived Organoids, 2020 to 2035
Figure 20: Global Organoids Market Value Share Analysis, By Application, 2024 and 2035
Figure 21: Global Organoids Market Attractiveness Analysis, By Application, 2025 to 2035
Figure 22: Global Organoids Market Revenue (US$ Bn), by Developmental Biology, 2020 to 2035
Figure 23: Global Organoids Market Revenue (US$ Bn), by Regenerative Medicine, 2020 to 2035
Figure 24: Global Organoids Market Revenue (US$ Bn), by Disease Modelling, 2020 to 2035
Figure 25: Global Organoids Market Revenue (US$ Bn), by Drug Toxicity and Efficacy Testing, 2020 to 2035
Figure 26: Global Organoids Market Revenue (US$ Bn), by Biomarker Discovery, 2020 to 2035
Figure 27: Global Organoids Market Revenue (US$ Bn), by Others, 2020 to 2035
Figure 28: Global Organoids Market Value Share Analysis, By Usability, 2024 and 2035
Figure 29: Global Organoids Market Attractiveness Analysis, By Usability, 2025 to 2035
Figure 30: Global Organoids Market Revenue (US$ Bn), by Ready-to-Use Organoids, 2020 to 2035
Figure 31: Global Organoids Market Revenue (US$ Bn), by Customizable Organoids, 2020 to 2035
Figure 32: Global Organoids Market Value Share Analysis, By Storage Conditions, 2024 and 2035
Figure 33: Global Organoids Market Attractiveness Analysis, By Storage Conditions, 2025 to 2035
Figure 34: Global Organoids Market Revenue (US$ Bn), by Shelf-stable Organoids, 2020 to 2035
Figure 35: Global Organoids Market Revenue (US$ Bn), by Cryopreserved Organoids, 2020 to 2035
Figure 36: Global Organoids Market Value Share Analysis, By End-user, 2024 and 2035
Figure 37: Global Organoids Market Attractiveness Analysis, By End-user, 2025 to 2035
Figure 38: Global Organoids Market Revenue (US$ Bn), by Pharmaceutical and Biotechnology Companies, 2020 to 2035
Figure 39: Global Organoids Market Revenue (US$ Bn), by Contract Research Organizations (CROs), 2020 to 2035
Figure 40: Global Organoids Market Revenue (US$ Bn), by Academic and Research Institutions, 2020 to 2035
Figure 41: Global Organoids Market Value Share Analysis, By Region, 2024 and 2035
Figure 42: Global Organoids Market Attractiveness Analysis, By Region, 2025 to 2035
Figure 43: North America Organoids Market Value (US$ Bn) Forecast, 2020 to 2035
Figure 44: North America Organoids Market Value Share Analysis, by Country, 2024 and 2035
Figure 45: North America Organoids Market Attractiveness Analysis, by Country, 2025 to 2035
Figure 46: North America Organoids Market Value Share Analysis, By Type of Organoid, 2024 and 2035
Figure 47: North America Organoids Market Attractiveness Analysis, By Type of Organoid, 2025 to 2035
Figure 48: North America Organoids Market Value Share Analysis, By Source, 2024 and 2035
Figure 49: North America Organoids Market Attractiveness Analysis, By Source, 2025 to 2035
Figure 50: North America Organoids Market Value Share Analysis, By Application, 2024 and 2035
Figure 51: North America Organoids Market Attractiveness Analysis, By Application, 2025 to 2035
Figure 52: North America Organoids Market Value Share Analysis, By Usability, 2024 and 2035
Figure 53: North America Organoids Market Attractiveness Analysis, By Usability, 2025 to 2035
Figure 54: North America Organoids Market Value Share Analysis, By Storage Conditions, 2024 and 2035
Figure 55: North America Organoids Market Attractiveness Analysis, By Storage Conditions, 2025 to 2035
Figure 56: North America Organoids Market Value Share Analysis, By End-user, 2024 and 2035
Figure 57: North America Organoids Market Attractiveness Analysis, By End-user, 2025 to 2035
Figure 58: Europe Organoids Market Value (US$ Bn) Forecast, 2020 to 2035
Figure 59: Europe Organoids Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
Figure 60: Europe Organoids Market Attractiveness Analysis, by Country / Sub-region, 2025 to 2035
Figure 61: Europe Organoids Market Value Share Analysis, By Type of Organoid, 2024 and 2035
Figure 62: Europe Organoids Market Attractiveness Analysis, By Type of Organoid, 2025 to 2035
Figure 63: Europe Organoids Market Value Share Analysis, By Source, 2024 and 2035
Figure 64: Europe Organoids Market Attractiveness Analysis, By Source, 2025 to 2035
Figure 65: Europe Organoids Market Value Share Analysis, By Application, 2024 and 2035
Figure 66: Europe Organoids Market Attractiveness Analysis, By Application, 2025 to 2035
Figure 67: Europe Organoids Market Value Share Analysis, By Usability, 2024 and 2035
Figure 68: Europe Organoids Market Attractiveness Analysis, By Usability, 2025 to 2035
Figure 69: Europe Organoids Market Value Share Analysis, By Storage Conditions, 2024 and 2035
Figure 70: Europe Organoids Market Attractiveness Analysis, By Storage Conditions, 2025 to 2035
Figure 71: Europe Organoids Market Value Share Analysis, By End-user, 2024 and 2035
Figure 72: Europe Organoids Market Attractiveness Analysis, By End-user, 2025 to 2035
Figure 73: Asia Pacific Organoids Market Value (US$ Bn) Forecast, 2020 to 2035
Figure 74: Asia Pacific Organoids Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
Figure 75: Asia Pacific Organoids Market Attractiveness Analysis, by Country/Sub-region, 2025 to 2035
Figure 76: Asia Pacific Organoids Market Value Share Analysis, By Type of Organoid, 2024 and 2035
Figure 77: Asia Pacific Organoids Market Attractiveness Analysis, By Type of Organoid, 2025 to 2035
Figure 78: Asia Pacific Organoids Market Value Share Analysis, By Source, 2024 and 2035
Figure 79: Asia Pacific Organoids Market Attractiveness Analysis, By Source, 2025 to 2035
Figure 80: Asia Pacific Organoids Market Value Share Analysis, By Application, 2024 and 2035
Figure 81: Asia Pacific Organoids Market Attractiveness Analysis, By Application, 2025 to 2035
Figure 82: Asia Pacific Organoids Market Value Share Analysis, By Usability, 2024 and 2035
Figure 83: Asia Pacific Organoids Market Attractiveness Analysis, By Usability, 2025 to 2035
Figure 84: Asia Pacific Organoids Market Value Share Analysis, By Storage Conditions, 2024 and 2035
Figure 85: Asia Pacific Organoids Market Attractiveness Analysis, By Storage Conditions, 2025 to 2035
Figure 86: Asia Pacific Organoids Market Value Share Analysis, By End-user, 2024 and 2035
Figure 87: Asia Pacific Organoids Market Attractiveness Analysis, By End-user, 2025 to 2035
Figure 88: Latin America Organoids Market Value (US$ Bn) Forecast, 2020 to 2035
Figure 89: Latin America Organoids Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
Figure 90: Latin America Organoids Market Attractiveness Analysis, by Country / Sub-region, 2025 to 2035
Figure 91: Latin America Organoids Market Value Share Analysis, By Type of Organoid, 2024 and 2035
Figure 92: Latin America Organoids Market Attractiveness Analysis, By Type of Organoid, 2025 to 2035
Figure 93: Latin America Organoids Market Value Share Analysis, By Source, 2024 and 2035
Figure 94: Latin America Organoids Market Attractiveness Analysis, By Source, 2025 to 2035
Figure 95: Latin America Organoids Market Value Share Analysis, By Application, 2024 and 2035
Figure 96: Latin America Organoids Market Attractiveness Analysis, By Application, 2025 to 2035
Figure 97: Latin America Organoids Market Value Share Analysis, By Usability, 2024 and 2035
Figure 98: Latin America Organoids Market Attractiveness Analysis, By Usability, 2025 to 2035
Figure 99: Latin America Organoids Market Value Share Analysis, By Storage Conditions, 2024 and 2035
Figure 100: Latin America Organoids Market Attractiveness Analysis, By Storage Conditions, 2025 to 2035
Figure 101: Latin America Organoids Market Value Share Analysis, By End-user, 2024 and 2035
Figure 102: Latin America Organoids Market Attractiveness Analysis, By End-user, 2025 to 2035
Figure 103: Middle East & Africa Organoids Market Value (US$ Bn) Forecast, 2020 to 2035
Figure 104: Middle East & Africa Organoids Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
Figure 105: Middle East & Africa Organoids Market Attractiveness Analysis, by Country / Sub-region, 2025 to 2035
Figure 106: Middle East & Africa Organoids Market Value Share Analysis, By Type of Organoid, 2024 and 2035
Figure 107: Middle East & Africa Organoids Market Attractiveness Analysis, By Type of Organoid, 2025 to 2035
Figure 108: Middle East & Africa Organoids Market Value Share Analysis, By Source, 2024 and 2035
Figure 109: Middle East & Africa Organoids Market Attractiveness Analysis, By Source, 2025 to 2035
Figure 110: Middle East & Africa Organoids Market Value Share Analysis, By Application, 2024 and 2035
Figure 111: Middle East & Africa Organoids Market Attractiveness Analysis, By Application, 2025 to 2035
Figure 112: Middle East & Africa Organoids Market Value Share Analysis, By Usability, 2024 and 2035
Figure 113: Middle East & Africa Organoids Market Attractiveness Analysis, By Usability, 2025 to 2035
Figure 114: Middle East & Africa Organoids Market Value Share Analysis, By Storage Conditions, 2024 and 2035
Figure 115: Middle East & Africa Organoids Market Attractiveness Analysis, By Storage Conditions, 2025 to 2035
Figure 116: Middle East & Africa Organoids Market Value Share Analysis, By End-user, 2024 and 2035
Figure 117: Middle East & Africa Organoids Market Attractiveness Analysis, By End-user, 2025 to 2035
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Organoids Market